| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
32,204 |
28,487 |
$2.30M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,520 |
7,774 |
$1.35M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
19,085 |
16,688 |
$1.01M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
11,800 |
10,715 |
$990K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
2,109 |
1,809 |
$832K |
| 80053 |
Comprehensive metabolic panel |
26,377 |
22,064 |
$622K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,932 |
7,797 |
$454K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
4,752 |
2,865 |
$320K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,839 |
2,501 |
$283K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
4,035 |
3,651 |
$270K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,472 |
1,371 |
$254K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,567 |
3,970 |
$235K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,398 |
3,010 |
$224K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
29,888 |
23,949 |
$190K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,646 |
2,669 |
$172K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,081 |
2,662 |
$152K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
3,705 |
2,847 |
$149K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
7,247 |
5,703 |
$130K |
| 81025 |
|
8,897 |
7,986 |
$122K |
| 87430 |
|
3,518 |
3,290 |
$117K |
| 87081 |
|
2,353 |
2,196 |
$114K |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
5,951 |
5,465 |
$111K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
3,590 |
3,247 |
$108K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,212 |
1,104 |
$107K |
| G0378 |
Hospital observation service, per hour |
2,592 |
1,984 |
$107K |
| 81001 |
|
17,902 |
15,734 |
$105K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,458 |
1,332 |
$105K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,887 |
2,592 |
$101K |
| 84484 |
|
9,457 |
7,036 |
$100K |
| 80306 |
|
2,802 |
2,517 |
$97K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,391 |
1,251 |
$97K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,464 |
2,258 |
$96K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,458 |
2,252 |
$85K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,548 |
4,097 |
$72K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,915 |
4,512 |
$66K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,544 |
1,419 |
$64K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
300 |
273 |
$61K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,997 |
3,609 |
$53K |
| 83690 |
|
8,519 |
7,405 |
$49K |
| 84702 |
|
1,964 |
1,514 |
$49K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
529 |
302 |
$45K |
| 87210 |
|
2,222 |
2,045 |
$41K |
| 12001 |
|
405 |
360 |
$38K |
| 80061 |
Lipid panel |
2,984 |
2,705 |
$36K |
| 87077 |
|
1,983 |
1,650 |
$36K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
3,821 |
3,482 |
$32K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
443 |
415 |
$31K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
112 |
94 |
$30K |
| 80050 |
General health panel |
1,994 |
1,801 |
$30K |
| 83880 |
|
1,370 |
1,199 |
$28K |
| 85379 |
|
2,818 |
2,563 |
$24K |
| 83735 |
|
4,400 |
3,505 |
$23K |
| 83605 |
|
2,813 |
2,114 |
$22K |
| 84439 |
|
2,257 |
2,012 |
$21K |
| 85610 |
|
3,793 |
2,948 |
$20K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
124 |
116 |
$20K |
| 87807 |
|
864 |
791 |
$20K |
| 87040 |
|
2,778 |
1,395 |
$19K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
123 |
119 |
$17K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
748 |
691 |
$17K |
| 29125 |
|
160 |
152 |
$16K |
| 82565 |
|
852 |
753 |
$14K |
| 85027 |
|
1,748 |
1,582 |
$14K |
| 86140 |
|
2,858 |
2,262 |
$13K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
149 |
137 |
$13K |
| 87186 |
|
1,797 |
1,518 |
$12K |
| 70496 |
|
174 |
151 |
$11K |
| 70498 |
|
164 |
143 |
$11K |
| 93017 |
|
240 |
227 |
$11K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
444 |
370 |
$10K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
112 |
100 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
170 |
148 |
$9K |
| 87088 |
|
1,440 |
1,231 |
$9K |
| 82728 |
|
749 |
661 |
$9K |
| 71046 |
Radiologic examination, chest; 2 views |
2,406 |
2,250 |
$8K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
224 |
107 |
$8K |
| 86480 |
|
113 |
106 |
$8K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,730 |
12,440 |
$7K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
171 |
156 |
$7K |
| 85730 |
|
1,897 |
1,673 |
$7K |
| 82950 |
|
879 |
821 |
$7K |
| 86481 |
|
81 |
78 |
$7K |
| 93971 |
|
203 |
196 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
72 |
68 |
$5K |
| 12011 |
|
40 |
38 |
$5K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
198 |
177 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
14,973 |
12,060 |
$4K |
| 85652 |
|
1,773 |
1,408 |
$4K |
| 94664 |
|
204 |
179 |
$4K |
| 87486 |
|
112 |
94 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
8,403 |
7,374 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
10,068 |
7,896 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
202 |
177 |
$3K |
| 87070 |
|
125 |
101 |
$3K |
| 90715 |
|
456 |
409 |
$3K |
| 83550 |
|
446 |
398 |
$3K |
| 85018 |
|
743 |
647 |
$3K |
| 87581 |
|
112 |
94 |
$3K |
| 76830 |
Ultrasound, transvaginal |
58 |
55 |
$3K |
| 80076 |
|
340 |
301 |
$2K |
| 83540 |
|
465 |
415 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,446 |
4,811 |
$2K |
| 82805 |
|
95 |
77 |
$2K |
| 74018 |
|
384 |
354 |
$2K |
| 84145 |
|
95 |
77 |
$1K |
| 76536 |
|
27 |
24 |
$1K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
14 |
12 |
$1K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
138 |
78 |
$1K |
| 0042T |
|
28 |
24 |
$1K |
| G0379 |
Direct admission of patient for hospital observation care |
31 |
27 |
$969.29 |
| 74178 |
|
12 |
12 |
$914.11 |
| 88304 |
|
109 |
94 |
$913.71 |
| 86900 |
|
407 |
340 |
$889.28 |
| 86901 |
|
407 |
340 |
$889.02 |
| 73630 |
|
932 |
848 |
$751.09 |
| 70486 |
|
29 |
26 |
$746.59 |
| 12002 |
|
14 |
13 |
$733.47 |
| 93225 |
|
43 |
38 |
$704.10 |
| 86850 |
|
103 |
90 |
$653.37 |
| 88312 |
|
938 |
721 |
$643.47 |
| 88174 |
|
47 |
39 |
$635.77 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
89 |
66 |
$541.55 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13 |
12 |
$484.82 |
| 72100 |
|
201 |
186 |
$439.71 |
| 73562 |
|
506 |
455 |
$380.27 |
| 97535 |
Self-care/home management training, each 15 minutes |
56 |
38 |
$368.17 |
| 88112 |
|
15 |
13 |
$359.41 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
17,412 |
13,981 |
$323.24 |
| 73502 |
|
62 |
54 |
$317.59 |
| 85007 |
|
63 |
52 |
$272.29 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
14 |
12 |
$260.91 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
8,187 |
6,779 |
$226.24 |
| 36415 |
Collection of venous blood by venipuncture |
2,671 |
1,865 |
$214.20 |
| 82550 |
|
51 |
42 |
$212.57 |
| 73610 |
|
1,008 |
927 |
$196.99 |
| 82607 |
|
14 |
12 |
$180.25 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
11,012 |
8,935 |
$172.82 |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
532 |
437 |
$158.07 |
| 97162 |
|
16 |
14 |
$147.22 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,974 |
2,593 |
$141.67 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,429 |
1,268 |
$137.20 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
9,553 |
7,344 |
$119.72 |
| 82150 |
|
14 |
13 |
$115.57 |
| 73130 |
|
460 |
404 |
$103.14 |
| 93226 |
|
29 |
26 |
$103.05 |
| 84703 |
|
16 |
15 |
$93.71 |
| 96376 |
|
2,393 |
1,676 |
$83.86 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
425 |
374 |
$81.34 |
| J3490 |
Unclassified drugs |
7,026 |
3,609 |
$80.05 |
| 73030 |
|
391 |
354 |
$66.29 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,240 |
5,280 |
$56.80 |
| 88342 |
|
13 |
12 |
$47.83 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
360 |
324 |
$42.33 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
1,811 |
1,383 |
$37.89 |
| 73110 |
|
283 |
259 |
$34.07 |
| 99152 |
|
190 |
173 |
$22.88 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,265 |
2,081 |
$19.07 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,123 |
979 |
$14.81 |
| 88313 |
|
96 |
82 |
$7.12 |
| J3480 |
Injection, potassium chloride, per 2 meq |
66 |
27 |
$6.81 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,585 |
9,645 |
$5.70 |
| 73560 |
|
54 |
49 |
$4.22 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
7,288 |
5,101 |
$1.74 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
108 |
89 |
$1.39 |
| J2704 |
Injection, propofol, 10 mg |
10,394 |
6,338 |
$1.15 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,382 |
2,473 |
$1.04 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
704 |
619 |
$0.96 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,167 |
1,734 |
$0.90 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
824 |
676 |
$0.50 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
3,899 |
3,224 |
$0.49 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
704 |
517 |
$0.25 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
454 |
410 |
$0.00 |
| A9270 |
Non-covered item or service |
2,692 |
1,804 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
175 |
145 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
196 |
184 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
847 |
623 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
188 |
163 |
$0.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
384 |
368 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
1,432 |
1,196 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
306 |
234 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
166 |
132 |
$0.00 |
| C1769 |
Guide wire |
103 |
90 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
488 |
422 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
39 |
37 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
52 |
39 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
34 |
24 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
92 |
77 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
24 |
24 |
$0.00 |
| 74019 |
|
49 |
48 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
15 |
15 |
$0.00 |
| 71101 |
|
15 |
15 |
$0.00 |
| 72040 |
|
12 |
12 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,202 |
1,762 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,310 |
916 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
223 |
131 |
$0.00 |
| 73140 |
|
27 |
26 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
192 |
174 |
$0.00 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
77 |
53 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
308 |
270 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
464 |
178 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
224 |
127 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
39 |
25 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
125 |
110 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
13 |
12 |
$0.00 |
| 73080 |
|
17 |
17 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
19 |
14 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
303 |
126 |
$0.00 |
| 73590 |
|
15 |
13 |
$0.00 |
| C1776 |
Joint device (implantable) |
14 |
13 |
$0.00 |